The Office of the Attorney General William Tong

Attorney General Tong Announces $400K Settlement With Waterbury Naturopath and Practice to Resolve Allegations of False Claims and Improper Billing

Attorney General William Tong and United States Attorney Vanessa Roberts Avery today announced a $399,440 settlement with Waterbury naturopath Marcos DeEscobar and his company Corebella Health, LLC to resolve allegations that they submitted false claims to, and received overpayments from, Medicare and the Connecticut Medicaid programs.

Attorney General Tong Statement Regarding Russian Sanctions

Attorney General William Tong released the following statement regarding news that he and other attorneys general who condemned the January 6 insurrection and defended the legitimacy of the 2020 election against baseless legal challenges have been banned from Russia and subjected to financial restrictions.

Attorney General Tong Sues Avid Telecom Over Illegal Robocalls

Attorney General William Tong today sued Michael D. Lansky, LLC, which does business under the name Avid Telecom, its owner Michael Lansky, and its vice president Stacey S. Reeves, for allegedly initiating and facilitating billions of illegal robocalls to millions of people and violating the Telephone Consumer Protection Act, the Telemarketing Sales Rule, and other federal and state telemarketing and consumer laws.

Attorney General Tong Defends Federal Restrictions on Handgun Sales to Individuals Under 21

Attorney General William Tong joined a coalition of 17 attorneys general filing an amicus brief with the U.S. Court of Appeals for the 5th Circuit defending the federal government’s longstanding prohibition on the sale of handguns and handgun ammunition by federally-licensed retailers to individuals under the age of 21.

Attorney General Tong Leads Bipartisan Coalition of 39 Attorneys General to Protect Communities from the Dangers of Illicit Xylazine

Attorney General William Tong today led a bipartisan coalition of 39 attorneys general urging Congressional leadership to pass the Combating Illicit Xylazine Act (H.R.1839/S.993), which would provide critical measures to combat the widespread illicit use and trafficking of xylazine and help prevent xylazine-related deaths.